Wednesday 14 October 2026

One To Watch

Bioprojet

A French pharmaceutical laboratory, organised across two entities.

Company Overview

Want to Update your Company's Profile?


Latest Bioprojet News

China's NMPA approves RareStone's Wakix for narcolepsy
5 July 2023
Harmony Biosciences gains US rights to pitolisant; raises $270 million
6 October 2017
More Bioprojet news >


Today's issue

MHRA approves Onswik for diabetes
Pharmaceutical
MHRA approves Onswik for diabetes
13 October 2026
Pharmaceutical
Nimbus hires Merck & Co dealmaker as chief business officer
13 October 2026
Biotechnology
Rona Thera inks global license deal with Roche
13 October 2026
Pharmaceutical
J&J lifts 2026 guidance as Tremfya surge offsets Stelara decline
13 October 2026
Biotechnology
Positive Phase IIb results for Tortugas' obuprazine in schizophrenia
13 October 2026
Biotechnology
Sibylla names ex-Novartis cell and gene therapy head Usman Azam CEO
13 October 2026
Biosimilars
Formycon and Zydus’s Keytruda biosimilar BLA accepted by FDA
13 October 2026




Copyright © The Pharma Letter 2026

 |  Headless Content Management with Blaze